Order of the High Court of Kerala regarding exorbitant pricing of life saving patented medicines.

The High Court wanted the opinion of the government of India on whether the breast cancer medicines and other such medicines can be made available to the less advantaged sections through alternative methods.

[2]

Counsel for the Central Government informed the HC that most of these medicines are already included in some scheme or the other, under which entitled persons will be able to obtain it at subsidised rates.

The HC adjourned the matter till November 22, 2023 within which time, the "competent authority of the Union of India will inform the court as to what is best alternative that can be offered to the patients of breast cancer in India" with respect to medicines for its treatment and whether it has already been included in specified schemes.